Clinical Trials in Pittsburgh

Showing 12421-12440 of 18,076 trials

An Observational Study of The Safety of MabThera/Rituxan (Rituximab) in Participants With Granulomatosis With Polyangiitis (Wegener's) or Microscopic Polyangiitis

NCT01613599

This prospective observational study will evaluate the long-term safety of MabThera/Rituxan (rituximab) in participants with granulomatosis with polyangiitis (Wegener's) or microscopic polyangiitis. Data will be collected for a maximum of 4 years from participants initiated on MabThera/Rituxan therapy by their physician according to prescribing information.

Granulomatosis With PolyangiitisMicroscopic Polyangiitis

Genentech, Inc.100 participantsStarted Jun 2012

Scottsdale, Arizona, United States • Los Angeles, California, United States • Jacksonville, Florida, United States +12 more locations

TERMINATEDPhase 2< 1 mile

Study of Efficacy and Safety of Buparlisib (BKM120) Plus Paclitaxel Versus Placebo Plus Paclitaxel in Recurrent or Metastatic Head and Neck Cancer Previously Pre-treated With a Platinum Therapy

NCT01852292

Phase II Study of efficacy and safety of buparlisib (BKM120) plus paclitaxel versus placebo plus paclitaxel in recurrent or metastatic Head and Neck cancer previously pre-treated with a platinum therapy.The primary endpoint was PFS and the key secondary endpoint was Overall Survival.

Head and Neck Squamous Cell Carcinoma

Novartis Pharmaceuticals157 participantsStarted Oct 2013

Fayetteville, Arkansas, United States • Boston, Massachusetts, United States • St Louis, Missouri, United States +55 more locations

An Observational Study of The Safety of MabThera/Rituxan (Rituximab) in Participants With Granulomatosis With Polyangiitis (Wegener's) or Microscopic Polyangiitis

Study of Efficacy and Safety of Buparlisib (BKM120) Plus Paclitaxel Versus Placebo Plus Paclitaxel in Recurrent or Metastatic Head and Neck Cancer Previously Pre-treated With a Platinum Therapy

Find Trials by Condition in Pittsburgh

Open Label Study of Long Term Safety Evaluation of Alirocumab

TARGET Intracranial Aneurysm Coiling Registry

Prospective Outcomes Study: Vectra® DA Guided Care Compared to Usual Care

Phase II Safety Study of Vemurafenib Followed by Ipilimumab in Subjects With V600 BRAF Mutated Advanced Melanoma

Rapid Amniotic Fluid (AF) Test and a Non-Invasive Vaginal Fluid (VF) Test

Brentuximab Vedotin for Steroid Refractory GvHD

Safety and Pharmacology of SNX-5422 Plus Everolimus in Subjects With Neuroendocrine Tumors

An Open-Label, Safety and Tolerability Study of Chronic Intermittent Use of Diazepam Nasal Spray.

A Two-Arm Study Evaluation H.P. Acthar Injection Gel in Treatment of Chronic Migraines

Intravenous Mepolizumab In Children With Eosinophilic Esophagitis

Safety/Pharmacokinetic Study Comparing Intracisternal EG-1962 to Standard of Care Enteral Nimodipine in Adults With aSAH

Post Approval NovaSure Essure Labeling Study

Efficacy and Safety of QVA149 in Patients With Chronic Obstructive Pulmonary Disease (COPD)

Phase IV O2 Consumption Study in COPD Patients.

Forteo for the Treatment of Unexplained Osteoporosis in Premenopausal Women

Combination Trial of Pimasertib (MSC1936369B) With Temsirolimus

A Trial Evaluating Efficacy & Safety of RVD +/- Panobinostat in Transplant Eligible, Newly Diagnosed Multiple Myeloma (NDMM)

Study of SB-742457 or Donepezil Versus Placebo in Subjects With Mild-to-moderate Alzheimer's Disease